Table of Contents
Relevance tier by entity
| Entity | Tier | Description |
|---|---|---|
 |
2 | Role of MKI67 mutations in BL requires confirmation |
 |
2 | Role of MKI67 mutations in FL requires confirmation |
Mutation incidence in large patient cohorts (GAMBL reanalysis)
BL
Failed to render page: conflicting chdir during another chdir block
FL
Failed to render page: conflicting chdir during another chdir block
DLBCL
Failed to render page: conflicting chdir during another chdir block
Mutation pattern and selective pressure estimates
Failed to render page: conflicting chdir during another chdir block
Failed to render page: conflicting chdir during another chdir block
Expression
Failed to render page: conflicting chdir during another chdir block
References
1.
Russler-Germain DA, Krysiak K, Ramirez CA,
Mosior M, Watkins MP, Gomez F, Skidmore ZL, Trani L, Gao F, Geyer S,
Cashen A, Mehta-Shah N, Kahl B, Bartlett N, Alderuccio J, Lossos I,
Ondrejka S, Hsi E, Martin P, Leonard J, Griffith M, Griffith O, Fehniger
T. Mutations
associated with progression in follicular lymphoma predict inferior
outcomes at diagnosis: Alliance A151303. Blood
Advances. 2023;7:5524–5539.
2.
Schmitz R, Young RM, Ceribelli M, Jhavar S,
Xiao W, Zhang M, Wright G, Shaffer AL, Hodson DJ, Buras E, Liu X, Powell
J, Yang Y, Xu W, Zhao H, Kohlhammer H, Rosenwald A, Kluin P,
Müller-Hermelink HK, Ott G, Gascoyne RD, Connors JM, Rimsza LM, Campo E,
Jaffe ES, Delabie J, Smeland EB, Ogwang MD, Reynolds SJ, Fisher RI,
Braziel RM, Tubbs RR, Cook JR, Weisenburger DD, Chan WC, Pittaluga S,
Wilson W, Waldmann TA, Rowe M, Mbulaiteye SM, Rickinson AB, Staudt LM.
Burkitt lymphoma pathogenesis and therapeutic targets from structural
and functional genomics. Nature. 2012 Oct 4;490(7418):116–120. PMCID: PMC3609867